ShareholdingMay 12, 2026, 06:12 AM
Innate Pharma Reports 93.9M Shares Outstanding as of April 16
AI Summary
Innate Pharma SA announced its total number of shares outstanding and voting rights as of April 16, 2026, in accordance with French regulations. The company reported 93,934,210 shares outstanding, with 93,921,863 theoretical voting rights and 93,903,288 exercisable voting rights. This update provides transparency on the company's capital structure.
Key Highlights
- Total shares outstanding: 93,934,210 shares.
- Ordinary shares: 93,921,863.
- Preferred Shares 2016: 4,766.
- Preferred Shares 2017: 7,581.
- Total theoretical voting rights: 93,921,863.
- Total exercisable voting rights: 93,903,288.
Price Impact
More from IPHA